Metformin Is Most Effective Diabetes Drug At Reducing BMI – AHRQ Report
Executive Summary
Metformin is more effective than thiazolidinediones and second generation sulfonylureas in decreasing weight and body mass index in type 2 diabetes patients, according to an Agency for Healthcare Research & Quality 1draft report
You may also be interested in...
Do Avandia Benefits Outweigh Risks? AHRQ, Consumer Reports Are Skeptical
An Agency for Healthcare Research & Quality report concluding thiazolidinediones are no more efficacious than metformin could put formulary pressure on the two marketed products in the class -GlaxoSmithKline's Avandia (rosiglitazone) and Lilly/Takeda's Actos (pioglitazone)
Do Avandia Benefits Outweigh Risks? AHRQ, Consumer Reports Are Skeptical
An Agency for Healthcare Research & Quality report concluding thiazolidinediones are no more efficacious than metformin could put formulary pressure on the two marketed products in the class -GlaxoSmithKline's Avandia (rosiglitazone) and Lilly/Takeda's Actos (pioglitazone)
GSK Pushing For ADOPTion Of Avandia For First-Line Type 2 Diabetes Therapy
GlaxoSmithKline plans to use the results of its ADOPT study to establish its thiazolidinedioneAvandia as the standard first-line treatment for type 2 diabetes